Oramed Pharmaceuticals Inc.
ORMP- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001176309
In the last 90 days, Oramed Pharmaceuticals Inc. insiders filed 0 open-market purchases and 2 sales; 84 institutions reported holding it in 13F filings for Q2 2026, worth $80.7M in total; no superinvestor holds it.
Q3 2022 vs. Q2 2022
How the institutions holding Oramed Pharmaceuticals Inc. changed between Q2 2022 and Q3 2022.
All holders in Q3 2022All holders in Q2 2022
| Measure | Q2 2022 | Of which not filed for Q3 2022 | Q3 2022 | Change |
|---|---|---|---|---|
| Holders | 89 | 2 | 71 | −16 |
| Shares | 6.60M | 3.66K | 3.94M | −2.66M (−40.3%) |
| Value | $31.0M | $17.0K | $25.5M | −$5.44M (−17.6%) |
2 institutions that held it in Q2 2022 haven't filed for Q3 2022 yet. Not filing isn't selling, so the changes leave them out.
New holders (3)
Institutions that held Oramed Pharmaceuticals Inc. at the end of Q3 2022 but not at the end of Q2 2022.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Walleye Capital LLC | 78,418 | $508.0K | 0.01% |
| Northwestern Mutual Wealth Management Co | 1,575 | $10.0K | 0.00% |
| Activest Wealth Management | 355 | $2.00K | 0.00% |
Sold out (19)
Institutions that held Oramed Pharmaceuticals Inc. at the end of Q2 2022 and filed for Q3 2022 without it.
| Institution | Shares, Q2 2022 | Value, Q2 2022 |
|---|---|---|
| Renaissance Technologies LLC | 359,697 | $1.65M |
| Bank of Montreal | 249,200 | $1.35M |
| Squarepoint Ops LLC | 116,065 | $532.0K |
| Oppenheimer & Co Inc | 50,000 | $229.0K |
| Rossmore Private Capital | 40,661 | $186.0K |
| Voloridge Investment Management, LLC | 20,868 | $96.0K |
| XTX Topco Ltd | 18,174 | $83.0K |
| Laurion Capital Management LP | 12,393 | $57.0K |
| Balyasny Asset Management LLC | 11,627 | $53.0K |
| Legal & General Group Plc | 3,022 | $14.0K |
| Sterling Investment Advisors, Ltd. | 3,150 | $14.0K |
| Ensign Peak Advisors, Inc | 1,760 | $8.00K |
| Geneos Wealth Management Inc. | 1,400 | $6.00K |
| Quantbot Technologies LP | 742 | $3.00K |
| ACG Wealth | 400 | $2.00K |
| New York State Common Retirement Fund | 260 | $1.00K |
| Clearstead Advisors, LLC | 250 | $1.00K |
| Credit Suisse AG | 20 | $0 |
| Point72 Hong Kong Ltd | 6 | $0 |
Not filed for Q3 2022 yet (2)
Institutions that held Oramed Pharmaceuticals Inc. at the end of Q2 2022 and haven't filed a 13F for Q3 2022. Not filing isn't selling, so they aren't counted as sold out.
| Institution | Shares, Q2 2022 | Value, Q2 2022 |
|---|---|---|
| Urban Wealth Management, LLC | 2,858 | $13.0K |
| Bivin & Associates, Inc. | 800 | $4.00K |